603456 九洲药业
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额654,0281,360,3241,225,782677,519400,392
投资活动产生之现金流量净额(747,138)(1,056,803)(738,417)(765,438)(210,532)
筹资活动产生之现金流量净额(477,783)2,102,185(608,963)582,429(116,123)
汇率变动对现金及现金等价物的影响(6,885)7,60557,611(22,591)(51,491)
现金及现金等价物净增加/(减少)(577,778)2,413,311(63,987)471,92022,245
期初现金及现金等价物余额3,076,069662,759726,746254,826232,581
期末现金及现金等价物余额2,498,2913,076,069662,759726,746254,826